Navigation Links
Rules-Based Medicine, Inc. Names Tony Barnes to Lead Expanding Diagnostics Business

AUSTIN, Texas, June 2 /PRNewswire/ -- Rules-Based Medicine, Incorporated (RBM), the leading biomarker testing service, today announced that Tony Barnes, Ph.D., MBA, has joined the Company as vice president, clinical diagnostics. Barnes will provide strategic marketing and operational leadership as RBM commercializes new biomarker-based diagnostic tests.

RBM, an established provider of multiplex biomarker assays for improved drug development, has programs to develop new diagnostic products targeting disease categories that currently lack accurate and objective tests. Commercialization programs underway include tests for schizophrenia and kidney disease. The Company has access to interesting and novel biomarker technology through partnerships with multiple companies and institutions, including companion diagnostic programs with major pharmaceutical companies.

Barnes brings to the Company 25 years experience in business development, senior management, marketing, operations and program management, gained at leading healthcare companies, such as Abbott Diagnostics, LifeScan Inc., and Ciba Corning Diagnostics. He also served as a strategic consultant for Booz Allen and Hamilton and consulted directly to major healthcare companies such as Ortho Pharma and Bristol-Myers Squibb.

Most recently, Barnes served as co-founder, chief executive officer and vice chairman of Oncimmune Ltd. During his six years with the company, Barnes developed and managed comprehensive technical, marketing and operations plans for the company and led the establishment of both the U.K. parent and U.S. subsidiary businesses. The first Oncimmune product, EarlyCDT-Lung(TM), a test for the early detection of lung cancer was launched in May 2009.

"As we establish new processes and infrastructure around our diagnostic programs, the additive value of Tony's extensive development, marketing, and operational experience will only strengthen our effort," said Craig Benson, RBM chief executive officer. "We are pleased to have him on board and welcome his insight and energy."

"RBM is positioned to accelerate the development of exciting and necessary diagnostic tests," said Barnes. "The Company is on the leading edge of multiplex assay technology that has the potential to enhance patient care. I look forward to working with the RBM management team and our collaborators to advance that vision."

About Rules-Based Medicine, Inc.

Rules-Based Medicine (RBM) provides comprehensive protein biomarker products and services centered on its Multi-Analyte Profiling (MAP) technology. Its service platform (RodentMAP(R) and HumanMAP(R)) provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins cost-effectively in multiple species, and from a small sample volume. The Company also offers innovative and proprietary ex vivo testing systems such as TruCulture(TM), the first fully-closed, reproducible whole blood culture system. RBM is actively developing multiplex diagnostic tests to detect the presence of complex diseases and conditions in areas of unmet medical need such as neuropsychiatry, nephrology, immunology and cardiology. More information about RBM is located at

RodentMAP(R) and HumanMAP(R) are registered trademarks of Rules-Based Medicine Inc.

SOURCE Rules-Based Medicine, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hofstra University to Establish New School of Medicine, Partnering with the North Shore-LIJ Health System
2. Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks
3. Tip sheet for the Annals of Internal Medicine, April 15, 2008, issue
4. Elsevier expands Procedures Consult with emergency medicine, orthopedics and anesthesia procedures
5. McGraw-Hill Professional Redesigns AccessMedicine, Highlighting Media and Educational Features
6. AMD Global Telemedicine, Inc. Forms Telemedicine Design Group
7. Healthcare Reform Should Include Connected Health and Participatory Medicine, Says Report Submitted to President Obama by Center for Connected Health
8. McGraw-Hill Professional and JAMA Launch New Online Evidence-Based Medicine, Clinical and Educational Resource
9. Local Infertility Specialist, Dr. Rachel Bennett, Westchester Reproductive Medicine, Opens New Office in Mount Kisco
10. AMD Global Telemedicine, Inc is Pleased to Announce the Selection of its Examination Camera for the Canadian National Telehealth Videoconference Equipment RFP
11. Penn Medicine, CHOP researchers demonstrate first common genetic risk factors for autism
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... November 27, 2015 , ... ProSidebar: Fashion is a set of ... With ProSidebar: Fasion, video editors can easily add an informative sidebar to any FCPX ... Utilize presets featuring self-animating drop zones, lines, bars, and text with the ease ...
(Date:11/27/2015)... ... ... simply groundbreaking television series, "Voices in America", which is hosted by Hollywood legend, James ... are presently affecting Americans. Dedicated to providing the world with a wide variety of ... focus on, one episode at a time. , In the latest installment currently ...
(Date:11/27/2015)... ... 27, 2015 , ... The men and women on this ... in the country. They have overseen financial turnarounds, shown commitment to their community ... industry as a whole through their advocacy and professional efforts. , Becker's Hospital ...
(Date:11/26/2015)... ... 2015 , ... Patients at Serenity Point Recovery, a holistic ... Thanksgiving Day to share the things that they are most grateful for today. ... channel, patients displayed what they wrote on index cards, describing the things that ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... --> adds "Global Repaglinide ... "Investigation Report on China Repaglinide Market, ... forecasts data and information to its ... . --> ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Italian ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Marker Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
Breaking Medicine Technology: